Etilevodopa | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Etilevodopa
USP

munit-sa-m-2025-04-14

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Etilevodopa

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 21 USDMF, 13 CEP/COS, 4 JDMF, 2 EU WC, 9 KDMF, 11 NDC API, 16 Listed Suppliers, $ API Reference Price

45 API Suppliers
21 USDMF
13 CEP/COS
4 JDMF
2 EU WC
9 KDMF
11 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

38 Drugs in Development

38 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

404 FDF Dossiers, 128 FDA Orange Book, 189 Europe, 30 Canada, 14 South Africa, 43 Listed Dossiers

404 FDF Dossiers
128 FDA Orange Book
189 Europe
30 Canada
14 South Africa
43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 4 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 8 DKSH, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 38 Controlled & Modified Release, 36 Direct Compression, 34 Solubilizers, 34 Thickeners and Stabilizers, 31 Granulation, 26 Taste Masking, 23 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 21 Parenteral, 21 Lubricants & Glidants, 17 Co-Processed Excipients, 14 Topical, 10 Rheology Modifiers, 8 API Stability Enhancers, 8 Emulsifying Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

87 Fillers, Diluents & Binders
65 Coating Systems & Additives
46 Disintegrants & Superdisintegrants
38 Controlled & Modified Release
36 Direct Compression
34 Solubilizers
34 Thickeners and Stabilizers
31 Granulation
26 Taste Masking
23 Film Formers & Plasticizers
21 Chewable & Orodispersible Aids
21 Parenteral
21 Lubricants & Glidants
17 Co-Processed Excipients
14 Topical
10 Rheology Modifiers
8 API Stability Enhancers
8 Emulsifying Agents
5 Coloring Agents
5 Empty Capsules
4 Surfactant & Foaming Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 97 News #PharmaBuzz

2 Data Compilation #PharmaFlow
97 News #PharmaBuzz

GLOBAL SALES INFORMATION

176 Regulatory FDF Prices, 16 Annual Reports

176 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

24 APIs, 5 FDF Dossiers

24 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

154 US Patents, 4 US Exclusivities

154 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 3 USP, 5 Others

1 EDQM
3 USP
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 86 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11361009

02 11361010

03 11420006

filter Description Reset all filters

3 All

01 1Levodopa (200 mg)

02 1Levodopa Related Compound A (50 mg) ((3-(2,4,5-Trihydroxyphenyl)-L-alanine) or (3-(3,4,6-Trihydroxyphenyl)alanine))

03 1Levodopa Related Compound B (50 mg) (3-methoxytyrosine)

filter CAS Number Reset all filters

3 All

01 127244-64-0

02 159-92-7

03 1N/A

Product Main Page

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Levodopa Related Compound B (50 mg) (3-methox...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1420006

Current Lot : J1J299

Previous Lot : J0J299 (31-AUG-2016)

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Levodopa (200 mg)

CAS Number : 59-92-7

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1361009

Current Lot : R035T0

Previous Lot : K0J392 (31-MAR-2017)

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Levodopa Related Compound A (50 mg) ((3-(2,4,...

CAS Number : 27244-64-0

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1361010

Current Lot : R044N0

Previous Lot : K1J271 (31-MAR-2017)

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!